75 Kazia Theraputics Limited Annual Report 2023 Chairman and CEO’s Letter Key Milestones Introduction to Kazia’s CEO Pipeline Review Environment, Society and Governance Financial Reports 2022 Tranche Grant date Expiry date Exercise price Balance at the start of the year Granted Exercised Expired / lapsed on termination of employment Balance at the end of the year 1 05/09/2016 05/09/2021 $1.6300 50,000 - - (50,000) - 2 12/10/2016 17/10/2021 $1.5600 62,000 - - (62,000) - 3 31/10/2016 01/11/2021 $1.3800 12,500 - - (12,500) - 4 21/11/2016 23/11/2021 $1.3800 50,000 - - (50,000) - 5 07/08/2017 07/08/2022 $0.6700 87,000 - (25,000) (46,500) 15,500 6 05/02/2018 05/02/2023 $0.7800 320,000 - - (80,000) 240,000 7 04/01/2019 04/01/2024 $0.4925 37,500 - - (37,500) - 8 13/11/2019 13/11/2023 $0.4925 1,200,000 - - - 1,200,000 9 13/01/2020 13/01/2025 $0.8812 200,000 - - - 200,000 10 09/11/2020 09/11/2024 $1.1320 1,200,000 - - - 1,200,000 11 09/11/2020 09/11/2024 $0.8812 800,000 - - - 800,000 12 04/01/2021 04/01/2026 $1.6900 200,000 - - - 200,000 13 09/09/2021 26/06/2026 $1.3700 - 100,000 - - 100,000 14 16/11/2021 16/11/2025 $1.6900 - 1,000,000 - - 1,000,000 15 16/11/2021 16/11/2025 $2.2400 - 1,500,000 - - 1,500,000 16 16/11/2021 16/11/2025 $1.5600 - 800,000 - - 800,000 17 01/02/2022 01/02/2027 $0.9400 - 800,000 - - 800,000 18 01/02/2022 01/02/2027 $0.9400 - 500,000 - - 500,000 19 24/05/2022 24/05/2027 $0.7800 - 100,000 - - 100,000 4,219,000 4,800,000 (25,000) (338,500) 8,655,500 Weighted average exercise price $0.8911 $1.6115 $0.6700 $1.1123 $1.2826 At the end of the period the following outstanding options were vested and exercisable: • Options in tranche 1-4 expired during the year • Options in tranches 1 - 8 were vested and exercisable, apart from those in the above table which have expired • Options in tranche 9 -10 were vested and exercisable to 50% • Options in tranche 11 were vested and exercisable to 75% • Options in tranche 12-14 were vested and exercisable to 25% • Options in tranche 15-19 were unvested The weighted average remaining contractual life of options outstanding at 30 June 2022 is 3.048 years. Note 32. Share-based payments continued
RkJQdWJsaXNoZXIy MjE2NDg3